.
Pharma stock hits 20% upper circuit after reporting 458% QoQ increase in  net profits 

Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines

The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.  With a market capitalization of Rs 447.73 crore, the shares of Venus Remedies Limited were trading at Rs 334.95 per share, increasing around 4.25 percent as compared to the previous closing price [...]
Pharma stock jumps 5% after company received award for its antibiotic product from UNICEF

Microcap stock jumps 8% after it secured a contract from UNICEF to supply antibiotic product

Share price of a company among the 10 leading fixed-dosage injectable manufacturers in the world, surged 8.4 percent to Rs. 384.95 in Thursday’s trading session, after the company secured a supply contract for its antibiotic product Ceftriaxone from UNICEF.  At 01:01 p.m., the shares of Venus Remedies Limited were trading in the green at Rs. [...]
Pharma stock hits 20% upper circuit after it received approval for sale of its cancer drugs

Pharma stock hits 20% upper circuit after it received approval for sale of its cancer drugs

On Monday, the shares of India's largest antibiotics drug maker surged 20 percent higher to Rs 272.90 per share after the business received marketing approval from the Philippines for six chemotherapy medications.  At 11:20 a.m., Venus Remedies Ltd shares hit a 20 percent upper circuit on the National Stock Exchange from the previous close price. [...]
Pharma stock hits 20% upper circuit after it received approval for sale of its cancer drugs

Pharma stock jumps 4% after company receives approval to operate in four foreign markets 

On Wednesday, the shares of a well-known Indian brand for affordable cancer treatments globally and one of the world's top ten fixed-dosage injectable producers rose 4%.  Venus Remedies Ltd ended at Rs 261.50 a share, up over 4%, after the company received marketing approval from four markets for the expansion of the Oncology products.  As [...]
×